Bindu Donovan is a partner in Desmarais LLP’s Life Sciences Practice, focusing on pharmaceutical, medical device and biologics patent litigation. She has more than 25 years of experience in life sciences patent litigation, including cases filed under the Hatch-Waxman Act on behalf of innovator drug companies. She has served as trial and litigation counsel for some of the world’s leading life sciences companies in complex, high stakes patent disputes, including cases involving cancer, influenza, diabetes, neurological and ophthalmic disorders, biotechnology, radiofrequency ablation probes, and drug-eluting stents. She also has significant experience conducting pre-litigation investigations involving biologics and small molecule drugs and coordinating global patent enforcement and defense strategies.
Representative matters include:
- Avanos Medical Sales, LLC v. Medtronic Sofamor Danek USA Inc. (W.D. Tenn.) – (counsel for Avanos in patent infringement suit involving cooled radiofrequency ablation products)
- Actelion Pharmaceuticals Ltd. et al. v. Zydus Pharmaceuticals (USA) Inc. (D.N.J.) and Actelion Pharmaceuticals Ltd. et al. v. Natco Pharma Ltd. et al. (D.N.J.) – (counsel for Johnson & Johnson subsidiary, Actelion Pharmaceuticals, in separate patent infringement suits filed under the Hatch-Waxman Act involving pulmonary arterial hypertension drug Tracleer® 32 mg tablets)
- BTG International Ltd., Janssen Biotech, Inc., Janssen Oncology Inc., Janssen Research & Development, LLC v. Actavis Labs. FL et al. (D.N.J.) – (counsel for Johnson & Johnson subsidiary, Janssen, in patent infringement suit filed under the Hatch-Waxman Act and inter partes review proceedings involving prostate cancer drug Zytiga®)
- Gilead Sciences, Inc., Hoffmann-LaRoche Inc., and Genentech, Inc. et al., v. Natco Pharma (D.N.J.) – (counsel for Gilead and Roche/Genentech in patent infringement suit filed under the Hatch-Waxman Act involving antiviral drug Tamiflu®)
- Cordis Corporation and Wyeth v. Abbott (D.N.J.); Cordis Corporation and Wyeth v. Abbott, Boston Scientific and Medtronic (D.N.J.); Boston Scientific v. Johnson & Johnson, Cordis Corporation and Wyeth (D. Del.) – (counsel for patent holders Cordis and Wyeth in series of patent infringement suits involving drug eluting stents)
- Noven Pharmaceuticals, Inc. v. Watson (D.N.J.) – (counsel for patent holder Noven Pharmaceuticals in patent infringement litigation filed under the Hatch-Waxman Act concerning transdermal patch for ADHD, Daytrana®)
- Eli Lilly and Company v. Actavis (D.N.J.) and Eli Lilly and Company v. Synthon (E.D. Va.) – (counsel for patent holder Eli Lilly in patent infringement litigations filed under the Hatch-Waxman Act concerning ADHD drug, Strattera®)
- SmithKline Beecham PLC v. Teva and Dr. Reddy’s Laboratories (D.N.J.) – (counsel for patent holder SmithKline Beecham in patent infringement litigations filed under the Hatch-Waxman Act concerning Type 2 diabetes drug Avandia®)
Updated Sep 2023
